Capricor Therapeutics Competitors and Similar CompaniesClear all
Capricor Therapeutics's competitors and similar companies include Keros Therapeutics, 19Labs, Stuart Therapeutics and LyGenesis.
 Capricor Therapeutics Capricor Therapeutics is a biotechnology company focused on the discovery, development & commercialization of first-in-class therapeutics for the treatment of diseases. |  Keros Therapeutics Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders. |  Stuart Therapeutics Stuart Therapeutics is a biotechnology company that develops a tissue reparative platform for eye diseases. |  LyGenesis LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. | ||
Founding Date | Founding Date 2005 | Founding Date 2015 | Founding Date 2015 | Founding Date 2018 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Beverly Hills, US HQ | Locations Lexington, US HQ | Locations San Mateo, US HQ Brentwood Bay, CA | Locations Stuart, US HQ | Locations Pittsburgh, US HQ Pittsburgh, US |
Employees | Employees 1854% decrease | Employees 23 | Employees 129% increase | Employees 8 | Employees 5 |
Valuation ($) | Valuation ($) 147.4 m | Valuation ($) 952.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Twitter followers | Twitter followers 7 | Twitter followers N/A | Twitter followers 252 | Twitter followers N/A | Twitter followers N/A |
Employee Rating | Employee Rating 2.1 | Employee Rating 2 | Employee Rating 3.5 | Employee Rating N/A | Employee Rating N/A |
Financial | |||||
Net income | Net income ($29m) (FY, 2022) | Net income ($104.7m) (FY, 2022) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 11m (over 2 years ago) | Latest funding round $ 4m (almost 4 years ago) |
Total funding raised | Total funding raised $ 78.5m | Total funding raised $ 90m | Total funding raised N/A | Total funding raised $ 11m | Total funding raised $ 7m |
For sources of this data, please see the company profile
View Company Profiles
Keros Therapeutics
HQ
Lexington, US
Employees
23
Keros Therapeutics is a biotechnology company dedicated to the discovery and development of therapeutics for hematological and musculoskeletal disorders.
View companyStuart Therapeutics
HQ
Stuart, US
Employees
8
Stuart Therapeutics is a biotechnology company that develops a tissue reparative platform for eye diseases.
View companyLyGenesis
HQ
Pittsburgh, US
Employees
5
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs.
View company